CoChat

Single Fluid-Filled Intragastric Balloon Safe and Effective for Inducing Weight Loss in a Real-World Population

Open access
Vargas, Eric J., Pesta, Carl M., Bali, Ahmad, Ibegbu, Eric, Bazerbachi, Fateh, Moore, Rachel L., Kumbhari, Vivek, Sharaiha, Reem Z., Curry, Trace W., DosSantos, Gina, Schmitz, Ramsey, Agnihotri, Abhishek, Novikov, Aleksey A., Pitt, Tracy, Dunlap, Margo K., Herr, Andrea, Aronne, Louis, Ledonne, Erin, Kadouh, Hoda C., Cheskin, Lawrence J., Mundi, Manpreet S., Acosta, Andres, Gostout, Christopher J., Abu Dayyeh, Barham K. · 2018 · Clinical Gastroenterology and Hepatology
Cited by 75

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

Background & Aims: The Orbera intragastric balloon (OIB) is a single fluid‐filled intragastric balloon approved for the induction of weight loss and treatment of obesity. However, little is known about the effectiveness and safety of the OIB outside clinical trials, and since approval, the Food and Drug Administration has issued warnings to health care providers about risk of balloon hyperinflation requiring early removal, pancreatitis, and death. We analyzed data on patients who have received the OIB since its approval to determine its safety, effectiveness, and tolerance in real‐world clinical settings. Methods: We performed a postregulatory approval study of the safety and efficacy of the OIB, and factors associated with intolerance and response. We collected data from the Mayo Clinic's database of patient demographics, outcomes of OIB placement (weight loss, weight‐related comorbidities), technical aspects of insertion and removal, and adverse events associated with the device and/or procedure, from 8 centers (3 academic, 5 private, 4 surgeons, and 4 gastroenterologists). Our final analysis comprised 321 patients (mean age, 48.1 ± 11.9 y; 80% female; baseline body mass index, 37.6 ± 6.9). Exploratory multivariable linear and logistic regression analyses were performed to identify predictors of success and early balloon removal. Primary effectiveness outcomes were percentage of total body weight lost at 3, 6, and 9 months. Primary and secondary safety outcomes were rates of early balloon removal, periprocedural complications, dehydration episodes requiring intravenous infusion, balloon migration, balloon deflation or hyperinflation, pancreatitis, or other complications. Results: Four patients had contraindications for placement at the time of endoscopy. The balloon was safely removed in all instances with an early removal rate (before 6 months) in 16.7% of patients, at a median of 8 weeks after placement (range, 1–6 mo). Use of selective serotonin or serotonin‐norepinephrine re‐uptake inhibitors at the time of balloon placement was associated with increased odds of removal before 6 months (odds ratio, 3.92; 95% CI, 1.24–12.41). Total body weight lost at 3 months was 8.5% ± 4.9% (n = 204), at 6 months was 11.8% ± 7.5% (n = 199), and at 9 months was 13.3% ± 10% (n = 47). At 6 months, total body weight losses of 5%, 10%, and 15% were achieved by 88%, 62%, and 31% of patients, respectively. Number of follow‐up visits and weight loss at 3 months were associated with increased weight loss at 6 months (&bgr; = 0.5 and 1.2, respectively) (P < .05). Mean levels of cholesterol, triglycerides, low‐density lipoprotein, and hemoglobin A1c, as well as systolic and diastolic blood pressure, were significantly improved at 6 months after OIB placement (P < .05). Conclusions: In an analysis of a database of patients who received endoscopic placement of the OIB, we found it to be safe, effective at inducing weight loss, and to reduce obesity‐related comorbidities in a real‐world clinical population. Rates of early removal (before 8 weeks) did not differ significantly between clinical trials and the real‐world population, but were affected by use of medications.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cgh.2018.01.046

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 75

Metadata

Authors
Vargas, E. J., Pesta, C. M., Bali, A., Ibegbu, E., Bazerbachi, F., Moore, R. L., Kumbhari, V., Sharaiha, R. Z., Curry, T. W., DosSantos, G., Schmitz, R., Agnihotri, A., Novikov, A. A., Pitt, T., Dunlap, M. K., Herr, A., Aronne, L., Ledonne, E., Kadouh, H. C., Cheskin, L. J., Mundi, M. S., Acosta, A., Gostout, C. J., & Abu Dayyeh, B. K.
Venue
Clinical Gastroenterology and Hepatology
Publisher
Elsevier BV
Published
2018-07
Volume
16
Issue
7
Pages
1073-1080.e1
ISSN
1542-3565 (ISSN-L)
OpenAlex
W2786408414
Cited by
75
References
17
FWCI
10.37
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.